In a study population of Taiwanese patients with lung cancer, a high frequency of TIMP-2 loss by LOH and/or promotor hypermethylation in E6-positive lung tumors was found compared with E6-negative lung tumors [104]. Here, TIMP2 is linked to lung cancer.